MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Autonomic dysfunction"

  • 2023 International Congress

    Unveiling the Link between Stress-Related Disorders and Dysautonomic Symptoms in Parkinson’s Disease: A Cross-Sectional Study

    EJ. Acosta-Espinoza, IA. Ortiz-Marroquin, DI. Salinas-Leal, A. Salinas-Blancas, HM. Macias-Cruz, D. Martinez-Ramirez (Monterrey, Mexico)

    Objective: To explore the link between post-traumatic stress disorders and dysautonomic symptoms in Parkinson's disease. Background: Parkinson's disease is a complex condition that can lead…
  • 2023 International Congress

    The Impact of Diabetes Mellitus on Motor and Non-Motor Symptoms of Parkinson’s Disease: A Cross-Sectional Study.

    IC. Rodriguez-Gonzalez, F. Botello-Villagrana, SR. Gomez-Villalobos, A. Gonzalez-Cantu, X. Torres-Mancilla, M. Gonzalez-Gonzalez, D. Martinez-Ramirez (Monterrey, Mexico)

    Objective: To evaluate the impact of Diabetes Mellitus on the clinical characteristics and symptoms of Parkinson's Disease. Background: Parkinson's disease (PD) is a prevalent neurodegenerative…
  • 2023 International Congress

    Comparison of the MIBG uptake in the major salivary glands between progressive supranuclear palsy/corticobasal syndrome and Parkinson’s disease

    J. Ebina, M. Shibukawa, H. Morioka, J. Nagasawa, M. Yanagihashi, T. Hirayama, N. Ishii, S. Mizumura, S. Orimo, O. Kano (Tokyo, Japan)

    Objective: To compare the MIBG uptake in the major salivary gland between progressive supranuclear palsy/corticobasal syndrome (PSP/CBS) and Parkinson’s disease (PD). Background: 123I-metaiodobenzylguanidine (MIBG) myocardial…
  • 2023 International Congress

    Chronotropic incompetence – a possible marker of severe Parkinson’s disease phenotype?

    M. Andréasson, P. Svenningsson (Stockholm, Sweden)

    Objective: Perform a retrospective analysis of patients with Parkinson’s disease (PD) who previously have undergone a cardiac stress test, with the aim of comparing clinical…
  • 2023 International Congress

    Association between supine hypertension and plasma free triiodothyronine in drug-naïve Parkinson’s disease

    T. Umehara, T. Kokubu, J. Takahashi, T. Shiraishi, T. Sato, A. Onda, I. Iguchi (Tokyo, Japan)

    Objective: We aimed to clarify the association between thyroid hormone levels and supine hypertension (SH) in patients with early Parkinson’s disease (PD). Background: Increasing evidence…
  • 2023 International Congress

    Longitudinal follow-up of pure autonomic failure with cardiac sympathetic denervation: Relevance to the body-first theory of Parkinson’s disease

    T. Fay Karmon, S. Hassin-Baer, Z. Shabtai, E. Druker, A. Leibowitz, Y. Sharabi (Petach Tikva, Israel)

    Objective: In this report, we describe eight patients with PAF with nOH and imaging evidence of cardiac sympathetic denervation by 123I-metaiodobenzylguanidine (123I-MBG) single photon emission…
  • 2023 International Congress

    Quantitative Evaluation of Seborrheic Dermatitis in Patients with Autonomic Dysfunction.

    R. Sengoku, A. Nakahara, T. Kitagawa, M. Ikeda, H. Matsuno (Tokyo, Japan)

    Objective: We quantitatively evaluated skin condition of patients with autonomic dysfunction. Background: Dyshidrosis are known to be one of autonomic symptom in Lewy body disease…
  • 2023 International Congress

    Vagus nerve degeneration in Parkinson’s disease: correlation with autonomic symptoms and pupillography

    M. Batchakaschvili, M. Löhle, HR. Kleinlein, W. Hermann, H. Walter, A. Storch, U. Walter (Rostock, Germany)

    Objective: To test the hypothesis that vagus nerve (VN) atrophy is pronounced in the body-first subtype of Parkinson’s disease (PD) and coincides with pupillary dysfunction.…
  • 2023 International Congress

    Blood Pressure Monitoring in Multiple System Atrophy: Focused on Nocturnal Dipping Pattern

    I. Jeremia, A. Tiksnadi, D. Tunjungsari (DKI Jakarta, Indonesia)

    Objective: To depict 24 hour blood pressure profile, especially dipping patterns, in subjects with probable and clinically established multiple system atrophy (MSA). Background: Impairment of…
  • 2023 International Congress

    Clinical characteristics of patients with dementia with Lewy bodies followed in a movement disorder clinic

    AS. Jakobsson, L. Salvesen, AM. Hejl (Copenhagen, Denmark)

    Objective: To describe the clinical phenotype of the subgroup of patients with Dementia with Lewy bodies (DLB) followed in a movement disorder setting rather than…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 24
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley